Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2004
03/17/2004CN1481799A Granule, capsule formulation of dimaltol vanadium complex for Diabetes and its use
03/17/2004CN1481795A A ophthalmic formulation for topical application
03/17/2004CN1481793A Ginkgo leaf extract and injection fluid containing same
03/17/2004CN1481792A Andrographolide soft capsule formulation and preparation method
03/17/2004CN1481791A Andrographolide microcapsule and its preparation method
03/17/2004CN1481787A Propylgallate injection and its preparing process
03/17/2004CN1481786A Method for preparing sotalol hydrochloride of injection
03/17/2004CN1481784A Slow releasing micro-encapsulation compound antioxidant
03/17/2004CN1481783A Medicine-carring particulates composed of hydrophilic resin and hydrophobic resin and its preparation method
03/17/2004CN1481782A Emulsifying method for preparing emulsion and associated suspension and particles
03/17/2004CN1142212C Coating and agglomerant for oral or dermal dosage forms
03/17/2004CN1142165C Preparation of partially synthesized deuteroporphyrin derivative and its freezing dried injection
03/17/2004CN1141981C Sponge material capable of promoting healing of spinal tissue wound, its preparing method and use
03/17/2004CN1141975C Process for preparing xenogenous or autogenous tumor vaccine of liposome
03/17/2004CN1141974C Oral biologic preparation of colon-positioning release
03/17/2004CN1141973C Capsule for curing diabetes and its preparation method
03/17/2004CN1141971C Ointment for treating cracked nipple
03/17/2004CN1141967C Externally applied traditional Chinese medicine oil for treating burns and scalds
03/17/2004CN1141963C Ointment for curing hemorrhoids
03/17/2004CN1141960C Traditional Chinese medicine composition applied via rectum and vagina for endometriosis and dysmenorrhea
03/17/2004CN1141953C Traditional Chinese medicine capsule for osteomyelitis and process
03/17/2004CN1141947C Syrup for treating cough and asthma and its production Process.
03/17/2004CN1141939C Method for producing naproxen delay releasing capsule
03/17/2004CN1141937C Pharmaceutical composition containing tramadol for preparing medicine of curing hemicrania and the like
03/17/2004CN1141935C Multiple encapsulation of oleophilic substances
03/17/2004CN1141934C Health-care oil for regulating blood fat
03/17/2004CN1141929C Medicament formulation
03/17/2004CN1141875C Use of aerogel in agriculture
03/16/2004US6706963 Photovoltaic cell interconnection
03/16/2004US6706892 Adminstering maleimide derivative to covalently bond protein; wound healing, antibiotic, antiinflammatory, anticarcinogenic, hypotensive, and analgesic agents
03/16/2004US6706877 Combining with vigorous stirring catalytically active mixture of alkali metal carbonate and fatty acid lower alkyl ester with emulsifier mixture of glycose component and carbohydrate partial ester to form emulsion/dispersion
03/16/2004US6706861 Reconstitution of purified membrane proteins into preformed liposomes
03/16/2004US6706836 Addition copolymerization of 2-hydroxyethyl methacrylate in ethylene glycol dimethacrylate and (meth)acrylic acid
03/16/2004US6706737 Inhibiting gastric acid secretion are known in the art and include a class of benzimidazole- substituted compounds, one of which is omeprazole
03/16/2004US6706732 Nasal preparation of guanidinoimino quinoline derivatives
03/16/2004US6706728 Topical cervix immune response modifiers of imidazoquinoline amines, imidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, and thiazoloquinoline amines
03/16/2004US6706695 Antilipemic formulation
03/16/2004US6706690 Hemoactive compositions and methods for their manufacture and use
03/16/2004US6706689 Administering glucagon like peptide-1 (glp-1), where the patient is not suffering from a q-wave myocardial infarction
03/16/2004US6706681 Stabilised with mannitol
03/16/2004US6706394 Method and apparatus for manufacture of magnetizable microparticles
03/16/2004US6706289 Methods and compositions for enhanced delivery of bioactive molecules
03/16/2004US6706288 Microparticles
03/16/2004US6706287 Microencapsulated or enteric coated composition comprising a probiotic, a prebiotic, and an ammoniaphilic urea degrading microorganism with high alkaline ph stability and high urease activity
03/16/2004US6706286 Process for the preparation of granular and porous sucralfate dry gel
03/16/2004US6706285 Enteric coated formulation of a benzimidazole derivative and method for preparation thereof
03/16/2004US6706283 Controlled release by extrusion of solid amorphous dispersions of drugs
03/16/2004US6706282 Sustained release osmotic dosage form without delayed release coating adapted for once a day administration as suspension or slurry; such as nefazodone
03/16/2004US6706281 Melt-extrusion multiparticulates
03/16/2004US6706280 Drug targeting with liposomes and magnetic resonance imaging contrast media for diagnostics
03/16/2004US6706276 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
03/16/2004US6706274 Differential delivery of nitric oxide
03/16/2004US6706263 Composition for alleviating symptoms of uremia in patients
03/16/2004US6706256 Oral care compositions
03/16/2004US6706255 Liquid pharmaceutical compositions comprising thyroid hormones
03/16/2004US6706034 Process for agent retention in biological tissues
03/16/2004US6706011 Laser assisted drug delivery
03/16/2004US6705757 Method and apparatus for preparing microparticles using in-line solvent extraction
03/16/2004CA2331446C Biodegradable sustained-release alginate gels
03/16/2004CA2265651C Immediate wettability water soluble film or water soluble layer for oral application
03/16/2004CA2223745C Method of solubilizing, purifying, and refolding protein
03/16/2004CA2124829C Osmotic device with delayed activation of drug delivery
03/16/2004CA2105887C Bioerodible device for administering active ingredients
03/16/2004CA2105165C Dosage form for a delayed drug-delivery
03/11/2004WO2004020969A2 Production of nanoparticles having a defined number of ligands
03/11/2004WO2004020552A1 Radical reaction inhibitors, method for inhibition of radical reactions, and use thereof
03/11/2004WO2004020289A1 Process for producing metered dose inhaler formulations
03/11/2004WO2004020189A1 Embossable and writable multilaminate backing construction
03/11/2004WO2004020079A1 Method for preparing colloidal solution of bismuth sodiun tartrate
03/11/2004WO2004020029A1 Therapeutic aerosol device
03/11/2004WO2004020011A1 Embolization
03/11/2004WO2004019999A2 Agent delivery particle
03/11/2004WO2004019988A1 Adhesive patch
03/11/2004WO2004019987A1 Adhesive patch
03/11/2004WO2004019985A1 Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
03/11/2004WO2004019982A1 Remedy
03/11/2004WO2004019977A2 Improved bacterial outer membrane vesicles
03/11/2004WO2004019957A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
03/11/2004WO2004019955A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
03/11/2004WO2004019937A1 Pharmaceutical composition of metaxalone with enhanced oral bioavailability
03/11/2004WO2004019930A1 Pasting agent
03/11/2004WO2004019925A1 Oral liquid tolterodine composition
03/11/2004WO2004019922A1 Breath freshening and oral cleansing product using citral
03/11/2004WO2004019920A1 Transdermal delivery system
03/11/2004WO2004019919A1 Skin friendly active ingredient plaster based on sbc, containing at least 34 wt % of a pharmaceutical active ingredient and production thereof
03/11/2004WO2004019918A1 Granulate or powder for producing coating or binding agents for medicaments
03/11/2004WO2004019917A1 Device for release of a drug containing oseltamivir and a h1 antagonist
03/11/2004WO2004019916A1 Vesicle-encapsulated corticosteroids for the treatment of cancer
03/11/2004WO2004019915A1 Vesicle-encapsulated corticosteroids for the treatment of cancer
03/11/2004WO2004019914A1 Lipid-polymer-conjugates compositions comprising corticosteroids for the treatment of cancer
03/11/2004WO2004019913A1 A pharmaceutical composition of small-sized liposomes and method of preparation
03/11/2004WO2004019912A2 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer
03/11/2004WO2004019911A2 Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders
03/11/2004WO2004019910A2 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
03/11/2004WO2004019909A2 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
03/11/2004WO2004019908A1 Colloidal drug carrier system
03/11/2004WO2004019907A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
03/11/2004WO2004019906A2 Method of manufacturing albumin microspheres comprising antisense oligonucleotides (oligomers) to nf-kb
03/11/2004WO2004019905A1 Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
03/11/2004WO2004019904A1 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma